CD44 and neoplasm: The extracellular domain (ETD) of CD44 undergoes binding of hyaluronic acid (HA) and triggers inhibition of cell proliferation, while an interrupted HA binding by ectodomain cleavage or inhibitors has been regarded as an antitumor strategy for high expression of CD44 in many tumor cells (5, 6, 7).